Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
3
×
life sciences
national blog main
boston blog main
boston top stories
san francisco blog main
acute migrane
ally bridge group
bain capital
bausch health
big data analytics
black diamond therapeutics
blackrock
bladder cancer
blueprint medicines
boston
breast cancer
cancer
cancer drugs
casdin capital
deciphera pharmaceuticals
desmoid tumor
diabetic nephropathy
dihydroergotamine
dihydroergotamine mesylate
eli lilly
endometral cancer
europe blog main
european society for medical oncology
eventide asset management
fda
focal segmental glomerulosclerosis
generic drug
glaxosmithkline
glioblastoma
goldfinch bio
impel neuropharma
irving investors
jay ghosh
What
biotech
3
×
drug
3
×
ipo
companies
lead
leading
medicines
new
activity
analysis
bio
black
bring
cancer
clinic
company
days
develop
diamond
diseases
dog
eluded
employing
firm
genetic
goldfinch
hasn’t
hopes
ipos
kidney
later
line
lines
migraine
million
molecular
nears
pfizer
phase
place
Language
unset
3
×
Current search:
drug
×
unset
×
" clinical trials "
×
biotech
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs